Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial.

Puntos clave

• To evaluate the effects of celecoxib combined with low-dose-rate brachytherapy on oncological outcomes and quality of life in prostate cancer.
• Post hoc analysis of an open-label controlled randomized trial
• Evaluation of long-term oncological outcomes
• Assessment of quality of life indicators
• Improvement in long-term oncological outcomes with the combination treatment
• Enhanced quality of life reported among participants receiving celecoxib and brachytherapy